Fibroblast growth factor  8 overexpression is predictive of poor prognosis in pancreatic ductal adenocarcinoma

ConclusionFGF8 is a  promising target for new anticancer therapies using FGF inhibitors in pancreatic ductal adenocarcinomas.
Source: European Surgery - Category: Surgery Source Type: research